 "Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt")
The promoter entity’s pledged shares in Apollo Hospitals Enterprise (AHEL) will come down to a manageable level.
It rose above 70 per cent a couple of quarters before, raising concerns in the market. At end-September, the promoter group shareholding was 30.8 per cent, of which about 66 per cent was pledged, according to a regulatory filing “The Apollo Munich transaction (stake sale in it) is expected to fructify over the next one month — a final leg of regulatory clearances is awaited. Once that (happens), we hope to see the promoter pledge also come down to a manageable 20-25 per cent.
